ecrin-mdr-crcClinical2018Colorectal cancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2676267China3ECRIN MDRNot yet recruitingfalseStudy on antiangiogenic transformation medicine of advanced colorectal cancer based on APE1 expressionInterventions: Experimental group:Endostar combined with FOLFOX;Control group:FOLFOX Primary outcome(s): PFS;ORR Study Design: Randomized parallel controlled trial2018-03-152676267ChiCTR1800014879